Bosutinib
targeted anticancer therapy · kinase inhibitor
Nothing to addBy the Layer Nutrition editorial team · How the atlas classifies the 664 molecules
What this medicine is for
Bosutinib belongs to the "targeted anticancer therapy (kinase inhibitor)" category. This targeted therapy attacks a specific mechanism of tumor cells; it requires a specialized hospital prescription.
Specifically, for Bosutinib: Treats a cancer by targeting tumor cells. Its prescription and administration fall within a specialized setting, often in hospital.
Under which brands it is found
Bosutinib is part of about 5 presentations listed in France. It is available under various trade names and as generics.
- Bosulif
- Bosutinib Biogaran
- Bosutinib Eg
- Bosutinib Teva
- Bosutinib Zentiva
Generics and the original brand are equivalent for the active substance; only the appearance, the name or the excipients may differ.
Do you need a supplement? No.
Nous n'avançons aucun complément pour Bosutinib : ce serait forcer un besoin qui n'existe pas. La grande majorité des médicaments n'appellent aucune supplémentation particulière, et le reconnaître fait partie de notre manière de travailler. Nous ne concevons un complément que là où les données le soutiennent.
Related molecules
To explore in the « Other areas » family and its neighbours.